Issue 4 2021

Acquisition International - Issue 4 2021 17 Helping To Prolong The Golden Years Founded in 2011, Kintaro Cells Power aims to use the power of mesenchymal stem cells to rejuvenate, increase life expectancy and improve the quality of life for all. Following the firm’s well-deserved success in the 2021 Global Excellence Awards, we caught up with Marushchak Illia Ph D, to find out more about one of the most innovative stem cells medical suppliers in Asia today. ased on more than 50 years of fundamental research and own patented technology, Kintaro Cells Power brings the highest quality of stem cell treatment to end users, possessing the ability to revitalise your body and increase your overall well-being from the inside. Going into further detail, Marushchak begins by providing us with a brief overview of the firm, as well as offering us more of an insight into the types of individuals their services greatly benefit. “Since inception, we have amassed more than 50 certificates and patents, showing that our stem cell research and technology is recognised by leading institutes worldwide. Kintaro Stem Cells are recommended for men and women who want to prolong the active period of their life and benefit throughout their golden years.” Across Asia, Kintaro Cells Power has local competitors in some countries, however, as Maruschak points out to us, the right business model, proven efficiency and commitment to innovation have allowed the firm to distance itself from the crowd. “Cellular therapy is effective in treating dozens of diseases and in antiaging, and thanks to partnerships with innovators in the market of different countries, as well as continuous improvement of technologies, we have achieved success.” Despite the outbreak of COVID-19, in many ways the firm have still managed to prosper during the pandemic as Marushchak explains further. B “Recently, we’ve seen the reports on a potential therapy for coronavirus (COVID-19) infections by stem cell transplant. This was highlighted in a recent article where a critically ill Chinese patients was saved by stem cell therapy. While this therapy is not a method to eradicate or cure coronavirus, there is evidence to support the concept that infected patients may be more likely to combat and survive the infection. “Firstly, stem cells resist viral attacks by the expression of certain genes known as interferon-gamma stimulated genes (ISGs). These are expressed in stem cells prior to their differentiation (Wu, X, et al, Cell 172: 423, 2018). Hence, stem cells would be expected to survive even if transplanted into a patient with an active coronavirus infection. Moreover, it is known that stem cells rejuvenate and regenerate cells in the body through various processes including reduction of inflammation, secretion of substances that protect cells, transfer of mitochondria, reduction of cell death, antioxidative effects and the improvement of immune system function.” Bringing the interview to a close, Marushchak reinforces the importance of Kintaro Cells Power as we look ahead to 2021 and beyond. “Stem cells make it possible to treat severe ailments such as diabetes, stroke and many others chronic diseases and they are able to increase life expectancy for an individual. The World Health Organisation (WHO) predicts that 30% of patients in clinics will receive stem cell injections by 2025, so our future prospects look very bright indeed.” Company: Kintaro Cells Power Corp Contact: Marushchak Illia Website: www.kintarocells.com Feb21299 “Since inception, we have amassed more than 50 certificates and patents, showing that our stem cell research and technology is recognised by leading institutes worldwide. Kintaro Stem Cells are recommended for men and women who want to prolong the active period of their life and benefit throughout their golden years.”